Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Mitochondrial cyclophilin D regulates T cell metabolic responses and disease tolerance to tuberculosis.

Tzelepis F, Blagih J, Khan N, Gillard J, Mendonca L, Roy DG, Ma EH, Joubert P, Jones RG, Divangahi M.

Sci Immunol. 2018 May 11;3(23). pii: eaar4135. doi: 10.1126/sciimmunol.aar4135.

PMID:
29752301
2.

Dissecting host cell death programs in the pathogenesis of influenza.

Downey J, Pernet E, Coulombe F, Divangahi M.

Microbes Infect. 2018 Apr 18. pii: S1286-4579(18)30093-5. doi: 10.1016/j.micinf.2018.03.005. [Epub ahead of print]

PMID:
29679740
3.

Mycobacterium tuberculosis and HIV Coinfection Brings Fire and Fury to Macrophages.

Khan N, Divangahi M.

J Infect Dis. 2018 Feb 8. doi: 10.1093/infdis/jix626. [Epub ahead of print] No abstract available.

PMID:
29432590
4.

Aged polymorphonuclear leukocytes cause fibrotic interstitial lung disease in the absence of regulation by B cells.

Kim JH, Podstawka J, Lou Y, Li L, Lee EKS, Divangahi M, Petri B, Jirik FR, Kelly MM, Yipp BG.

Nat Immunol. 2018 Feb;19(2):192-201. doi: 10.1038/s41590-017-0030-x. Epub 2018 Jan 15.

PMID:
29335647
5.

BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against Tuberculosis.

Kaufmann E, Sanz J, Dunn JL, Khan N, Mendonça LE, Pacis A, Tzelepis F, Pernet E, Dumaine A, Grenier JC, Mailhot-Léonard F, Ahmed E, Belle J, Besla R, Mazer B, King IL, Nijnik A, Robbins CS, Barreiro LB, Divangahi M.

Cell. 2018 Jan 11;172(1-2):176-190.e19. doi: 10.1016/j.cell.2017.12.031.

PMID:
29328912
6.

Cracking the Vaccine Code in Tuberculosis.

Divangahi M, Behr MA.

Am J Respir Crit Care Med. 2018 Feb 15;197(4):427-432. doi: 10.1164/rccm.201707-1489PP. No abstract available.

PMID:
29045159
7.

RIPK3 interacts with MAVS to regulate type I IFN-mediated immunity to Influenza A virus infection.

Downey J, Pernet E, Coulombe F, Allard B, Meunier I, Jaworska J, Qureshi S, Vinh DC, Martin JG, Joubert P, Divangahi M.

PLoS Pathog. 2017 Apr 14;13(4):e1006326. doi: 10.1371/journal.ppat.1006326. eCollection 2017 Apr.

8.

Bcl-xL mediates RIPK3-dependent necrosis in M. tuberculosis-infected macrophages.

Zhao X, Khan N, Gan H, Tzelepis F, Nishimura T, Park SY, Divangahi M, Remold HG.

Mucosal Immunol. 2017 Nov;10(6):1553-1568. doi: 10.1038/mi.2017.12. Epub 2017 Apr 12.

9.

Unravelling the networks dictating host resistance versus tolerance during pulmonary infections.

Meunier I, Kaufmann E, Downey J, Divangahi M.

Cell Tissue Res. 2017 Mar;367(3):525-536. doi: 10.1007/s00441-017-2572-5. Epub 2017 Feb 6. Review.

PMID:
28168323
10.

Intestinal helminth infection impacts the systemic distribution and function of the naive lymphocyte pool.

King IL, Mohrs K, Meli AP, Downey J, Lanthier P, Tzelepis F, Fritz JH, Tumanov AV, Divangahi M, Leadbetter EA, Mohrs M.

Mucosal Immunol. 2017 Sep;10(5):1160-1168. doi: 10.1038/mi.2016.127. Epub 2017 Jan 25.

11.

Semaphorin 4C Protects against Allergic Inflammation: Requirement of Regulatory CD138+ Plasma Cells.

Xue D, Kaufman GN, Dembele M, Beland M, Massoud AH, Mindt BC, Fiter R, Fixman ED, Martin JG, Friedel RH, Divangahi M, Fritz JH, Mazer BD.

J Immunol. 2017 Jan 1;198(1):71-81. Epub 2016 Nov 23.

12.

Tuberculosis.

Pai M, Behr MA, Dowdy D, Dheda K, Divangahi M, Boehme CC, Ginsberg A, Swaminathan S, Spigelman M, Getahun H, Menzies D, Raviglione M.

Nat Rev Dis Primers. 2016 Oct 27;2:16076. doi: 10.1038/nrdp.2016.76. Review.

PMID:
27784885
13.

Divergent impact of Toll-like receptor 2 deficiency on repair mechanisms in healthy muscle versus Duchenne muscular dystrophy.

Mojumdar K, Giordano C, Lemaire C, Liang F, Divangahi M, Qureshi ST, Petrof BJ.

J Pathol. 2016 May;239(1):10-22. doi: 10.1002/path.4689. Epub 2016 Mar 16.

PMID:
26800321
14.

Efferocytosis: Burying cell corpses to regulate tolerance and immunity.

Divangahi M.

Oncotarget. 2015 Jun 20;6(17):14721-2. No abstract available.

15.

Evolution of the Immune Response to Chronic Airway Colonization with Aspergillus fumigatus Hyphae.

Urb M, Snarr BD, Wojewodka G, Lehoux M, Lee MJ, Ralph B, Divangahi M, King IL, McGovern TK, Martin JG, Fraser R, Radzioch D, Sheppard DC.

Infect Immun. 2015 Sep;83(9):3590-600. doi: 10.1128/IAI.00359-15. Epub 2015 Jun 29.

16.

Alveolar macrophages and type I IFN in airway homeostasis and immunity.

Divangahi M, King IL, Pernet E.

Trends Immunol. 2015 May;36(5):307-14. doi: 10.1016/j.it.2015.03.005. Epub 2015 Apr 3. Review.

PMID:
25843635
17.

The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo.

Blagih J, Coulombe F, Vincent EE, Dupuy F, Galicia-Vázquez G, Yurchenko E, Raissi TC, van der Windt GJ, Viollet B, Pearce EL, Pelletier J, Piccirillo CA, Krawczyk CM, Divangahi M, Jones RG.

Immunity. 2015 Jan 20;42(1):41-54. doi: 10.1016/j.immuni.2014.12.030. Epub 2015 Jan 2.

18.

Annexin1 regulates DC efferocytosis and cross-presentation during Mycobacterium tuberculosis infection.

Tzelepis F, Verway M, Daoud J, Gillard J, Hassani-Ardakani K, Dunn J, Downey J, Gentile ME, Jaworska J, Sanchez AM, Nédélec Y, Vali H, Tabrizian M, Kristof AS, King IL, Barreiro LB, Divangahi M.

J Clin Invest. 2015 Feb;125(2):752-68. doi: 10.1172/JCI77014. Epub 2014 Dec 22.

19.

Toll-like receptor 4 ablation in mdx mice reveals innate immunity as a therapeutic target in Duchenne muscular dystrophy.

Giordano C, Mojumdar K, Liang F, Lemaire C, Li T, Richardson J, Divangahi M, Qureshi S, Petrof BJ.

Hum Mol Genet. 2015 Apr 15;24(8):2147-62. doi: 10.1093/hmg/ddu735. Epub 2014 Dec 30.

20.

Freund's adjuvant, NOD2 and mycobacteria.

Behr MA, Divangahi M.

Curr Opin Microbiol. 2015 Feb;23:126-32. doi: 10.1016/j.mib.2014.11.015. Epub 2014 Dec 5. Review.

PMID:
25483349
21.

Inflammatory monocytes promote progression of Duchenne muscular dystrophy and can be therapeutically targeted via CCR2.

Mojumdar K, Liang F, Giordano C, Lemaire C, Danialou G, Okazaki T, Bourdon J, Rafei M, Galipeau J, Divangahi M, Petrof BJ.

EMBO Mol Med. 2014 Nov;6(11):1476-92. doi: 10.15252/emmm.201403967.

22.

Targeting eicosanoid pathways in the development of novel anti-influenza drugs.

Coulombe F, Divangahi M.

Expert Rev Anti Infect Ther. 2014 Nov;12(11):1337-43. doi: 10.1586/14787210.2014.966082. Epub 2014 Sep 30. Review.

PMID:
25269880
23.

NLRX1 prevents mitochondrial induced apoptosis and enhances macrophage antiviral immunity by interacting with influenza virus PB1-F2 protein.

Jaworska J, Coulombe F, Downey J, Tzelepis F, Shalaby K, Tattoli I, Berube J, Rousseau S, Martin JG, Girardin SE, McCullers JA, Divangahi M.

Proc Natl Acad Sci U S A. 2014 May 20;111(20):E2110-9. doi: 10.1073/pnas.1322118111. Epub 2014 May 5.

24.

Targeted prostaglandin E2 inhibition enhances antiviral immunity through induction of type I interferon and apoptosis in macrophages.

Coulombe F, Jaworska J, Verway M, Tzelepis F, Massoud A, Gillard J, Wong G, Kobinger G, Xing Z, Couture C, Joubert P, Fritz JH, Powell WS, Divangahi M.

Immunity. 2014 Apr 17;40(4):554-68. doi: 10.1016/j.immuni.2014.02.013. Epub 2014 Apr 10.

25.

N-glycolylated peptidoglycan contributes to the immunogenicity but not pathogenicity of Mycobacterium tuberculosis.

Hansen JM, Golchin SA, Veyrier FJ, Domenech P, Boneca IG, Azad AK, Rajaram MV, Schlesinger LS, Divangahi M, Reed MB, Behr MA.

J Infect Dis. 2014 Apr 1;209(7):1045-54. doi: 10.1093/infdis/jit622. Epub 2013 Nov 21.

PMID:
24265438
26.

Vitamin D induces interleukin-1β expression: paracrine macrophage epithelial signaling controls M. tuberculosis infection.

Verway M, Bouttier M, Wang TT, Carrier M, Calderon M, An BS, Devemy E, McIntosh F, Divangahi M, Behr MA, White JH.

PLoS Pathog. 2013;9(6):e1003407. doi: 10.1371/journal.ppat.1003407. Epub 2013 Jun 6.

27.

Dying to live: how the death modality of the infected macrophage affects immunity to tuberculosis.

Divangahi M, Behar SM, Remold H.

Adv Exp Med Biol. 2013;783:103-20. doi: 10.1007/978-1-4614-6111-1_6. Review.

28.

Negative regulation of lung inflammation and immunopathology by TNF-α during acute influenza infection.

Damjanovic D, Divangahi M, Kugathasan K, Small CL, Zganiacz A, Brown EG, Hogaboam CM, Gauldie J, Xing Z.

Am J Pathol. 2011 Dec;179(6):2963-76. doi: 10.1016/j.ajpath.2011.09.003. Epub 2011 Oct 14.

29.

Lipids, apoptosis, and cross-presentation: links in the chain of host defense against Mycobacterium tuberculosis.

Behar SM, Martin CJ, Nunes-Alves C, Divangahi M, Remold HG.

Microbes Infect. 2011 Aug;13(8-9):749-56. doi: 10.1016/j.micinf.2011.03.002. Epub 2011 Mar 31. Review.

30.

Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis.

Behar SM, Martin CJ, Booty MG, Nishimura T, Zhao X, Gan HX, Divangahi M, Remold HG.

Mucosal Immunol. 2011 May;4(3):279-87. doi: 10.1038/mi.2011.3. Epub 2011 Feb 9. Review.

31.

CD8+ T-cell expansion and maintenance after recombinant adenovirus immunization rely upon cooperation between hematopoietic and nonhematopoietic antigen-presenting cells.

Bassett JD, Yang TC, Bernard D, Millar JB, Swift SL, McGray AJ, VanSeggelen H, Boudreau JE, Finn JD, Parsons R, Evelegh C, Damjanovic D, Grinshtein N, Divangahi M, Zhang L, Xing Z, Wan Y, Bramson JL.

Blood. 2011 Jan 27;117(4):1146-55. doi: 10.1182/blood-2010-03-272336. Epub 2010 Nov 18.

32.

Inhibition of monocyte chemoattractant protein-1 prevents diaphragmatic inflammation and maintains contractile function during endotoxemia.

Labbe K, Danialou G, Gvozdic D, Demoule A, Divangahi M, Boyd JH, Petrof BJ.

Crit Care. 2010;14(5):R187. doi: 10.1186/cc9295. Epub 2010 Oct 7.

33.

Increased upper airway cytokines and oxidative stress in severe obstructive sleep apnoea.

Kimoff RJ, Hamid Q, Divangahi M, Hussain S, Bao W, Naor N, Payne RJ, Ariyarajah A, Mulrain K, Petrof BJ.

Eur Respir J. 2011 Jul;38(1):89-97. doi: 10.1183/09031936.00048610. Epub 2010 Sep 16.

34.

Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy?

Behar SM, Divangahi M, Remold HG.

Nat Rev Microbiol. 2010 Sep;8(9):668-74. doi: 10.1038/nrmicro2387. Epub 2010 Aug 2. Review.

35.

What's in a name? The (mis)labelling of Crohn's as an autoimmune disease.

Behr MA, Divangahi M, Lalande JD.

Lancet. 2010 Jul 17;376(9736):202-3. doi: 10.1016/S0140-6736(10)60282-6. No abstract available.

PMID:
20638565
36.

Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis.

Divangahi M, Desjardins D, Nunes-Alves C, Remold HG, Behar SM.

Nat Immunol. 2010 Aug;11(8):751-8. doi: 10.1038/ni.1904. Epub 2010 Jul 11.

37.

Inspiratory resistive breathing induces acute lung injury.

Toumpanakis D, Kastis GA, Zacharatos P, Sigala I, Michailidou T, Kouvela M, Glynos C, Divangahi M, Roussos C, Theocharis SE, Vassilakopoulos T.

Am J Respir Crit Care Med. 2010 Nov 1;182(9):1129-36. doi: 10.1164/rccm.201001-0116OC. Epub 2010 Jul 9.

PMID:
20622034
38.

A novel anti-inflammatory role for secretory phospholipase A2 in immune complex-mediated arthritis.

Boilard E, Lai Y, Larabee K, Balestrieri B, Ghomashchi F, Fujioka D, Gobezie R, Coblyn JS, Weinblatt ME, Massarotti EM, Thornhill TS, Divangahi M, Remold H, Lambeau G, Gelb MH, Arm JP, Lee DM.

EMBO Mol Med. 2010 May;2(5):172-87. doi: 10.1002/emmm.201000072.

39.

Lack of CFTR in skeletal muscle predisposes to muscle wasting and diaphragm muscle pump failure in cystic fibrosis mice.

Divangahi M, Balghi H, Danialou G, Comtois AS, Demoule A, Ernest S, Haston C, Robert R, Hanrahan JW, Radzioch D, Petrof BJ.

PLoS Genet. 2009 Jul;5(7):e1000586. doi: 10.1371/journal.pgen.1000586. Epub 2009 Jul 31.

40.

Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide.

Coulombe F, Divangahi M, Veyrier F, de Léséleuc L, Gleason JL, Yang Y, Kelliher MA, Pandey AK, Sassetti CM, Reed MB, Behr MA.

J Exp Med. 2009 Aug 3;206(8):1709-16. doi: 10.1084/jem.20081779. Epub 2009 Jul 6.

41.

Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair.

Divangahi M, Chen M, Gan H, Desjardins D, Hickman TT, Lee DM, Fortune S, Behar SM, Remold HG.

Nat Immunol. 2009 Aug;10(8):899-906. doi: 10.1038/ni.1758. Epub 2009 Jun 28.

42.

Chemokine receptor and ligand upregulation in the diaphragm during endotoxemia and Pseudomonas lung infection.

Demoule A, Divangahi M, Yahiaoui L, Danialou G, Gvozdic D, Petrof BJ.

Mediators Inflamm. 2009;2009:860565. doi: 10.1155/2009/860565. Epub 2009 Apr 29.

43.

NOD2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity.

Divangahi M, Mostowy S, Coulombe F, Kozak R, Guillot L, Veyrier F, Kobayashi KS, Flavell RA, Gros P, Behr MA.

J Immunol. 2008 Nov 15;181(10):7157-65.

44.

Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death.

Chen M, Divangahi M, Gan H, Shin DS, Hong S, Lee DM, Serhan CN, Behar SM, Remold HG.

J Exp Med. 2008 Nov 24;205(12):2791-801. doi: 10.1084/jem.20080767. Epub 2008 Oct 27.

45.

Airway delivery of soluble mycobacterial antigens restores protective mucosal immunity by single intramuscular plasmid DNA tuberculosis vaccination: role of proinflammatory signals in the lung.

Jeyanathan M, Mu J, Kugathasan K, Zhang X, Damjanovic D, Small C, Divangahi M, Petrof BJ, Hogaboam CM, Xing Z.

J Immunol. 2008 Oct 15;181(8):5618-26.

46.

Critical negative regulation of type 1 T cell immunity and immunopathology by signaling adaptor DAP12 during intracellular infection.

Divangahi M, Yang T, Kugathasan K, McCormick S, Takenaka S, Gaschler G, Ashkar A, Stampfli M, Gauldie J, Bramson J, Takai T, Brown E, Yokoyama WM, Aoki N, Xing Z.

J Immunol. 2007 Sep 15;179(6):4015-26.

47.

Impact of IL-10 on diaphragmatic cytokine expression and contractility during Pseudomonas Infection.

Divangahi M, Demoule A, Danialou G, Yahiaoui L, Bao W, Xing Z, Petrof BJ.

Am J Respir Cell Mol Biol. 2007 Apr;36(4):504-12. Epub 2006 Nov 22.

PMID:
17122368
48.

Intramuscular immunization with a monogenic plasmid DNA tuberculosis vaccine: Enhanced immunogenicity by electroporation and co-expression of GM-CSF transgene.

Zhang X, Divangahi M, Ngai P, Santosuosso M, Millar J, Zganiacz A, Wang J, Bramson J, Xing Z.

Vaccine. 2007 Jan 26;25(7):1342-52. Epub 2006 Oct 10.

PMID:
17052817
49.

Toll-like receptors differentially regulate CC and CXC chemokines in skeletal muscle via NF-kappaB and calcineurin.

Boyd JH, Divangahi M, Yahiaoui L, Gvozdic D, Qureshi S, Petrof BJ.

Infect Immun. 2006 Dec;74(12):6829-38. Epub 2006 Sep 18.

50.

Endotoxin triggers nuclear factor-kappaB-dependent up-regulation of multiple proinflammatory genes in the diaphragm.

Demoule A, Divangahi M, Yahiaoui L, Danialou G, Gvozdic D, Labbe K, Bao W, Petrof BJ.

Am J Respir Crit Care Med. 2006 Sep 15;174(6):646-53. Epub 2006 Jun 15.

PMID:
16778157

Supplemental Content

Loading ...
Support Center